To elucidate the mechanism of action underlying the reduction in migration induced by mTOR inhibitors, we investigated the gene expression of ADAM 10 and ADAM 17, two factors promoting tumor invasiveness by degradation of the extracellular matrix and by inducing the epithelial–mesenchimal transition (EMT) [24,25]. This evidence concerns the gene MTOR and neoplasm.